Anna Martner
Goeteborg, O 41390, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
NRF2 activation by myeloid cell-derived oxidative stress induces SNAI-driven features of EMT in breast cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 20, 2026
Tumor microenvironment-mediated interactions between macrophages and cancer cells define immunoregulatory transcriptional programs.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 18, 2026
Myeloid Cell-Derived Thrombospondin-1 Mediates Anti-Metastatic Effects of Histamine Dihydrochloride in B16 Melanoma.
Journal: ImmunoTargets and therapy
Published: January 20, 2026
Immunogenicity of the Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in patients with cirrhosis.
Journal: Scandinavian journal of gastroenterology
Published: June 17, 2025
Influence of viral load on severity and mortality in COVID-19.
Journal: Infectious diseases (London, England)
Published: April 07, 2025
Non-Secretor Status Due to FUT2 Stop Mutation Is Associated with Reduced Rotavirus Infections but Not with Other Enteric Pathogens in Rwandan Children.
Journal: Microorganisms
Published: March 20, 2025
Histamine dihydrochloride and low-dose interleukin-2 in an emerging landscape of relapse prevention in acute myeloid leukemia.
Journal: Therapeutic advances in hematology
Published: January 24, 2025
Targeting murine metastatic cancers with cholera toxin A1-adjuvanted peptide vaccines.
Journal: Human vaccines & immunotherapeutics
Published: January 23, 2025
Consistency of the efficacy of immunotherapy with histamine dihydrochloride and low-dose interleukin-2 for relapse prevention in acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: December 24, 2024
Reply to: Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: August 30, 2024
Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors after allogeneic hematopoietic stem cell transplantation.
Journal: Scientific reports
Published: May 28, 2024
Histamine dihydrochloride and low-dose interleukin-2 has anti-leukemic efficacy in NPM1-mutated and myelomonocytic/monocytic acute myeloid leukemia.
Journal: Haematologica
Published: March 22, 2024
Last Updated: 09/26/2026